InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

XXII Stock Earnings: 22nd Century Group Misses Revenue for Q2 2024

By InvestorPlace Earnings

XXII stock results show that 22nd Century Group missed on revenue for the second quarter of 2024.

CNTA Stock Earnings: Centessa Pharmaceuticals Misses EPS for Q2 2024

By InvestorPlace Earnings

CNTA stock results show that Centessa Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.

IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

IMTX stock results show that Immatics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q2 2024

By InvestorPlace Earnings

JSPR stock results show that Jasper Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q2 2024

By InvestorPlace Earnings

RPHM stock results show that Reneo Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.

Load More